| |
 |
Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
|
| |
|
pp.71-81 (11) Authors: Joseph Ciccolini, Alexandre Evrard, Pierre Cuq |
| |
|
|
| |
|
Design of Novel Antitumor DNA Alkylating Agents: The Benzacronycine Series
|
| |
|
pp.83-92 (10) Authors: Marie-Helene David-Cordonnier, William Laine, Thomas Gaslonde, Sylvie Michel, Francois Tillequin, Michel Koch, Stephane Leonce, Alain Pierre, Christian Bailly |
| |
|
|
| |
|
Recent Anticancer Cytotoxic Agents
|
| |
|
pp.93-121 (29) Authors: Paolo Cozzi, Nicola Mongelli, Antonino Suarato |
| |
|
|
| |
|
Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
|
| |
|
pp.123-138 (16) Authors: Patrizia Russo, Maura Loprevite, Alfredo Cesario, Andrea Ardizzoni |
| |
|
|
| |
|
Epidermal Growth Factor Receptor Inhibitors: A New Prospective in the Treatment of Lung Cancer
|
| |
|
pp.139-148 (10) Authors: M. Tiseo, M. Loprevite, A. Ardizzoni |
| |
|
|
| |
|
Extending Nature's Leads: The Anticancer Agent Ellipticine
|
| |
|
pp.149-172 (24) Authors: Nichola C. Garbett, David E. Graves |
| |
|
|
| |
|
Plant-Derived Protein Tyrosine Kinase Inhibitors as Anticancer Agents
|
| |
|
pp.173-197 (25) Authors: Ferenc Hollosy, Gyorgy Keri |
| |
|
|
